3-Chloro-4-methoxybenzoic Acid

We are 3-Chloro-4-methoxybenzoic Acid CAS:37908-96-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-Chloro-4-methoxybenzoic Acid
CAS.NO:37908-96-6
Synonyms:3-Chloro-4-methoxybenzoic Acid
3-Chloro-p-anisic Acid
Molecular Formula:C8H7ClO3
Molecular Weight:186.59200
 
Physical and Chemical Properties:
Density:1.352
Melting point:216-218ºC
Boiling point:304.8ºC
Index of Refraction:138.2
 
Specification:
Appearance:White to beige powder
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:3-Chloro-4-Methoxybenzoic Acid is used in the synthesis of cyclooxygenase-2 (COX-2) inhibitors, NSAIDs used in the treatment of inflammation or pain.

3-Chloro-4-methoxybenzoic Acid


Related News: In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.3-BROMO-2-HYDROXY-5-METHYLPYRIDINE Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity.(3R)-3-<(tert-Butyldimethylsilyl)oxy>pentanedioic acid 1-<(R)-mandelic acid> ester We manufacture APIs and drug manufacturers make medicines from APIs.benzyl 2,3,3a,4,5,6,7,7a-octahydro-1H-indole-2-carboxylate,hydrochloride We manufacture APIs and drug manufacturers make medicines from APIs.“CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.

Related Products
Product Name
4-Chloro-2,3-Dimethylpyridine 1-Oxide View Details
1,8-Diazabicyclo[5.4.0]undec-7-ene View Details
Lixisenatide View Details
4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile manufacturer Triethoxyvinylsilane manufacturer 1,10-Dichlorodecane manufacturer 1-(4-nitrophenyl)sulfonyl-1,2,4-triazole manufacturer 1-Bromo-2,3,4,5,6-pentafluorobenzene manufacturer